Oxy

Description

Oxy Advanced Care Maximum Strength 3-in-1 Acne Pads are formulated to provide targeted treatment for acne. These pads combine multiple active ingredients to address various aspects of acne management. The product is designed for topical application and is presented in a convenient pad format, facilitating ease of use. Each pad is pre-soaked with a solution that delivers effective acne-fighting properties directly to the skin. The formulation aims to reduce the appearance of blemishes, prevent new breakouts, and promote clearer skin.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively clears acne pimples and facilitates the healing of the skin. The formulation penetrates pores to control the formation of blackheads and whiteheads, while also helping to prevent the emergence of new acne pimples.

There are no teratogenic or nonteratogenic effects associated with this drug.

Dosage and Administration

Healthcare professionals are advised to initiate treatment by thoroughly cleaning the affected skin area with a wipe. A thin layer of the medication should be applied to cover the entire affected area. The recommended frequency of application is one to three times daily.

To minimize the risk of excessive skin drying, it is recommended to start with one application per day. Based on the patient's response and as directed by a physician, the frequency may be gradually increased to two or three times daily if necessary.

In cases where bothersome dryness or peeling occurs, the application frequency should be reduced to once daily or every other day to alleviate these symptoms.

Contraindications

The product should not be left on the skin. This precaution is essential to prevent potential skin irritation or adverse reactions. No other contraindications have been specified.

Warnings and Precautions

For external use only. It is imperative to avoid contact with the eyes, lips, and mouth. In the event of accidental contact, the affected area should be flushed thoroughly with water to mitigate any potential irritation.

The concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. To minimize the risk of adverse effects, it is recommended that only one topical acne medication be used at a time.

Users should not leave the pad on the skin for extended periods. In case of accidental ingestion, immediate medical assistance should be sought, or the local Poison Control Center should be contacted without delay.

Pregnant or breastfeeding individuals are advised to consult a healthcare professional prior to use to ensure safety for both the mother and child.

Side Effects

Patients using this product may experience skin irritation and dryness, particularly if another topical acne medication is used concurrently. It is advised that only one topical acne medication be utilized at a time to minimize the risk of irritation.

This product is for external use only. In the event of accidental ingestion, patients should seek medical assistance or contact a Poison Control Center immediately. It is crucial to keep this product out of reach of children to prevent any potential harm.

Drug Interactions

The concurrent use of multiple topical acne medications may increase the risk of skin irritation and dryness. To mitigate this risk, it is advised that only one topical acne medication be used at a time. If irritation occurs, discontinuation of one of the medications should be considered to alleviate symptoms. Monitoring for signs of skin irritation is recommended when initiating or adjusting treatment regimens involving topical acne therapies.

Packaging & NDC

Below are the non-prescription pack sizes of Oxy (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be advised to keep this medication out of reach of children. In the event of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is recommended.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. Monitoring for potential adverse effects and therapeutic efficacy is recommended in this population.

Pregnancy

Pregnant patients and those who are breastfeeding should consult a healthcare professional prior to using this medication. It is important to assess the potential risks and benefits associated with its use during pregnancy and lactation. The safety of this medication in pregnant women has not been established, and caution is advised to ensure the well-being of both the mother and the fetus.

Lactation

Lactating mothers are advised to consult a health professional prior to using this medication. There is currently no available data on the excretion of this drug in human breast milk or its effects on breastfed infants. Therefore, caution is recommended when administering this medication to lactating individuals.

Renal Impairment

Patients with renal impairment have not been specifically addressed in the available prescribing information. There are no dosage adjustments, special monitoring requirements, or safety considerations outlined for individuals with reduced kidney function. Healthcare professionals should exercise caution and consider the lack of data when prescribing to this patient population.

Hepatic Impairment

Patients with hepatic impairment have not been specifically studied in relation to this medication. Consequently, there are no established dosage adjustments, special monitoring requirements, or precautions outlined for individuals with compromised liver function. It is recommended that healthcare providers exercise caution when prescribing this medication to patients with hepatic impairment, given the lack of data on its safety and efficacy in this population. Regular monitoring of liver function may be prudent in these cases, although specific parameters are not defined in the available information.

Overdosage

In the event of an overdosage, immediate medical assistance is crucial. If the substance is ingested, healthcare professionals should advise patients or caregivers to seek medical help or contact a Poison Control Center without delay.

Prompt intervention is essential to mitigate potential adverse effects associated with overdosage. Symptoms may vary depending on the specific substance involved; therefore, a thorough assessment by a medical professional is recommended to determine the appropriate course of action.

Management procedures may include supportive care and symptomatic treatment, tailored to the individual patient's needs. It is imperative that healthcare providers remain vigilant and prepared to address any complications that may arise from an overdosage scenario.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert text.

Patient Counseling

Healthcare providers should advise patients to keep the product out of reach of children to prevent accidental ingestion. Instruct patients that if the product is swallowed, they should seek medical help or contact a Poison Control Center immediately.

Patients should be informed to avoid contact with the eyes, lips, and mouth. In the event of contact, they should flush the area thoroughly with water. It is important to discuss the potential for skin irritation and dryness, particularly if patients are using another topical acne medication concurrently. Patients should be counseled to use only one topical acne medication at a time to minimize the risk of irritation.

Additionally, healthcare providers should emphasize that patients should not leave the pad on the skin for extended periods. Finally, patients who are pregnant or breastfeeding should be encouraged to consult a health professional before using the product to ensure safety.

Storage and Handling

The product is supplied in a tightly sealed container to ensure its integrity. It is essential to protect the product from freezing and to avoid exposure to flame, fire, and heat. Storage conditions should be maintained at temperatures not exceeding 100°F (38°C). Additionally, it is important to refrain from flushing the product. Proper handling and storage are crucial to maintain the quality and efficacy of the product.

Additional Clinical Information

No further data are available.

Drug Information (PDF)

This file contains official product information for Oxy, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)